Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maha Dessougi"'
Autor:
Ibrahim Almaghlouth, Amal Al Harthi, Mohammed A. Omair, Jawza Albaqami, Haya M. Almalag, Hanan H Abouzaid, Eman Alfi, Maha Dessougi, Lamya Alnaim, Mohamed Bedaiwi, Rawan Alshalhoub
Publikováno v:
Open Access Rheumatology: Research and Reviews. 12:193-202
Background Methotrexate (MTX) Intolerance Severity Score (MISS) has been previously validated in the Arabic language and has helped to detect high levels of intolerance in rheumatoid arthritis (RA) patients. The aim of the current study was to evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47c821e909d9fbc0f16bca87bff12c65
https://doi.org/10.2147/oarrr.s263287
https://doi.org/10.2147/oarrr.s263287
Autor:
Khalid Alismael, Mohammed K Bedaiwi, Waleed Husain, Mohammed A. Omair, Hind Alhumaidan, Hana Al Khabbaz, Maha Dessougi, Fatmah K. AlDuraibi, Salman Al Saleh, Moheeb Al Awwami, Sultana Abdulaziz, Maha A. Omair, Ibrahim Alahmadi
Publikováno v:
Clinical Rheumatology. 36:1537-1543
The prevalence of HLA-B27 in the general population and in axial spondyloarthritis (axSpA) patients in Saudi Arabia is unknown. The aim of this study was to evaluate the prevalence of HLA-B27 in these two populations and describe the delay in diagnos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b83e6118860f04893f22c902633c709b
https://doi.org/10.1007/s10067-017-3655-0
https://doi.org/10.1007/s10067-017-3655-0
Autor:
Hanan Al-Rayes, Suzan M. Attar, Sultana Abdulaziz, A. H. A. Albeity, A. Taruti, Hussein Halabi, Maha Dessougi, A. Alhouri, Sami Bahlas
Publikováno v:
Annals of the Rheumatic Diseases. 79:1483.1-1484
Background:Diffuse alveolar hemorrhage (DAH) is a rare and potentially lethal complication of systemic lupus erythematosus (SLE) with a high mortality rate. It occurs more frequently in patients with lupus nephritis (LN).Objectives:The aim of our stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb4374288c9aa90b2119266b3c8b3cf0
https://doi.org/10.1136/annrheumdis-2020-eular.2953
https://doi.org/10.1136/annrheumdis-2020-eular.2953
Autor:
Rawan Alshalhoub, Haya M. Almalag, Mohammed A. Omair, Amal Al Harthi, Maha Dessougi, Mohamed Bedaiwi, Jawza Albaqami
Publikováno v:
International journal of rheumatic diseases. 22(8)
Aim Methotrexate (MTX) is the anchor drug for the treatment of rheumatoid arthritis (RA). MTX is associated with adverse events that limit its use. The MTX intolerance severity score (MISS) was developed to identify symptoms related to MTX use in juv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da415be8e4b6bb343b97263d41208301
https://pubmed.ncbi.nlm.nih.gov/31245906
https://pubmed.ncbi.nlm.nih.gov/31245906
Autor:
Albaqami, Jawza1,2 (AUTHOR), Alshalhoub, Rawan1 (AUTHOR), Almalag, Haya1 (AUTHOR), Dessougi, Maha3 (AUTHOR), Al Harthi, Amal3 (AUTHOR), Bedaiwi, Mohamed K.4 (AUTHOR), Omair, Mohammed A.4 (AUTHOR) momair@ksu.edu.sa
Publikováno v:
International Journal of Rheumatic Diseases. Aug2019, Vol. 22 Issue 8, p1572-1577. 6p.
Autor:
Almalag, Haya, Abouzaid, Hanan H, Alnaim, Lamya, Albaqami, Jawza, AlShalhoub, Rawan, Almaghlouth, Ibrahim, Dessougi, Maha, Harthi, Amal Al, Bedaiwi, Mohamed, Alfi, Eman, Omair, Mohammed A
Publikováno v:
Open Access Rheumatology: Research & Reviews; Sep2020, Vol. 12, p193-202, 10p